Acetazolamideuracnc
This test measures the amount of acetazolamide in your urine to monitor drug levels and ensure proper dosing.
{"Acetazolamide is a medication used to treat glaucoma, altitude sickness, and certain types of edema","This urine test checks if the drug is being properly eliminated from your body","The test helps doctors ensure you're receiving the right dose for effective treatment","Results help monitor kidney function and drug efficacy","Abnormal levels may indicate dosing issues or kidney problems"}
Key facts at a glance
- LOINC
- 16309-7
- Short code
- ACET-U
- Synonyms
- acetaZOLAMIDE Ur-aCnc
- Category
- chemistry
- Sample
- urine
- Container
- Sterile polypropylene urine container with leak-proof lid
- Units
- N/A
- Ref low
- 5
- Ref high
- 20
- Critical range
- — – 30 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–100 years
- Method
- Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
- CPT
- 80307
- SNOMED
- 373549005
- Specimen volume
- Minimum 5 mL, preferred 10-15 mL
- Stability
- Room temperature: 24 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C): 30 days
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 24–72 hours
- Order
- routine
What is this test?
The urine acetazolamide test measures how much acetazolamide is present in your urine. Acetazolamide (brand name Diamox) is a prescription diuretic medication that helps reduce fluid buildup in the body. It works by increasing urine production and is commonly used to treat conditions such as glaucoma (to reduce eye pressure), altitude sickness, and certain types of swelling (edema).
This test is typically performed on a urine sample collected over a 24-hour period, though spot urine samples may also be used depending on your doctor's orders. The sample is analyzed in a laboratory to determine the concentration of acetazolamide and its metabolites.
Reference range
Therapeutic range: 5-20 mcg/mL; Toxic level: >20 mcg/mLN/A
Collect mid-stream clean-catch urine sample. Avoid contamination with fecal material. Inform laboratory of any current medications or supplements. No fasting required.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Monitoring acetazolamide levels in urine helps healthcare providers assess whether the drug is being properly metabolized and eliminated by the kidneys. This is important because: 1) Proper dosing ensures the medication is effective for your condition, 2) The kidneys play a key role in eliminating acetazolamide from the body, so abnormal levels may indicate kidney function issues, 3) Some patients may experience side effects if the drug accumulates to high levels, and 4) The test can help confirm medication compliance.
Abnormally low levels might suggest that the medication is not being taken as prescribed, or that the body is eliminating it too quickly. Abnormally high levels could indicate kidney dysfunction, overdose, or that the dose needs adjustment. Your doctor will interpret these results in the context of your overall health and the condition being treated.
Frequently asked questions
Why do I need this test?
How is the urine sample collected?
Does this test require any special preparation?
What do the results mean?
Are there any risks with this test?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy